Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)

CUSIP: 61225M102

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
+5,937,410
Put/Call ratio
24%
SEC-reported price per share
$3.74
Number of holders
73
Value change
+$21,976,071
Number of buys
44
Open additional details 1 more signal available
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
85,185,185

Security key

61225M102

Report period

Q2 2024

Institutions

73

Top holders

10

Ownership snapshot

Top reported holders of GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bradley J. Bolzon PhD
Disclosed value leader
Bradley J. Bolzon PhD
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5 13F Highest disclosed value: $169,044,007 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bradley J. Bolzon PhD has the largest disclosed position value at $169.04M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bradley J. Bolzon PhD's linked filing trail.
Disclosed position value Top 5
Bradley J. Bolzon PhD $169.04M
Anthony A. Florence Jr. $146.15M
Carmen Chang $146.15M
Forest Baskett $146.15M
Joshua Makower $146.15M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bradley J. Bolzon PhD
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$169,044,007
8,944,185 shares
mixed-class rows
— 28 Jun 2021
Anthony A. Florence Jr.
3/4/5
10%+ Owner
—
denominator unverified
$146,153,662
7,692,298 shares
— 28 Jun 2021
Carmen Chang
3/4/5
10%+ Owner
—
denominator unverified
$146,153,662
7,692,298 shares
— 28 Jun 2021
Forest Baskett
3/4/5
10%+ Owner
—
denominator unverified
$146,153,662
7,692,298 shares
— 28 Jun 2021
Joshua Makower
3/4/5
10%+ Owner
—
denominator unverified
$146,153,662
7,692,298 shares
— 28 Jun 2021
Liza Landsman
3/4/5
10%+ Owner
—
denominator unverified
$146,153,662
7,692,298 shares
— 28 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
73
Shares
45,836,316
Rows available
73
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
67
Q2 2024 holders
73
Holder diff
6
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .